Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study

[1]  Fei-Fei Liu,et al.  HPV Associated Head and Neck Cancer , 2016, Cancers.

[2]  F. Khuri,et al.  Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial. , 2013, The Lancet. Oncology.

[3]  Young Seok Kim,et al.  Can concurrent chemoradiotherapy replace surgery and postoperative radiation for locally advanced stage III/IV tonsillar squamous cell carcinoma? , 2013, Anticancer research.

[4]  M. Canis,et al.  Results of transoral laser microsurgery in 102 patients with squamous cell carcinoma of the tonsil , 2012, European Archives of Oto-Rhino-Laryngology.

[5]  Dong-Wan Kim,et al.  Definitive Radiotherapy versus Postoperative Radiotherapy for Tonsil Cancer , 2012, Cancer research and treatment : official journal of Korean Cancer Association.

[6]  E. Vokes,et al.  DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F) (TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced squamous cell carcinoma of the head and neck (SCCHN). , 2012 .

[7]  Il-Seok Park,et al.  Pattern of cervical lymph node metastasis in tonsil cancer: predictive factor analysis of contralateral and retropharyngeal lymph node metastasis. , 2011, Oral oncology.

[8]  M. Black,et al.  A 20‐year retrospective study of tonsil cancer incidence and survival trends in South East England: 1987–2006 , 2011, Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery.

[9]  Guo-Pei Yu,et al.  Population‐based analysis of oral and oropharyngeal carcinoma: Changing trends of histopathologic differentiation, survival and patient demographics , 2010, The Laryngoscope.

[10]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[11]  A. Garden,et al.  Outcomes of patients with tonsillar carcinoma treated with post‐tonsillectomy radiation therapy , 2009, Head & neck.

[12]  T. Loree,et al.  Oropharyngeal cancer: current understanding and management , 2009, Current opinion in otolaryngology & head and neck surgery.

[13]  W. Westra.  The Changing Face of Head and Neck Cancer in the 21st Century: The Impact of HPV on the Epidemiology and Pathology of Oral Cancer , 2009, Head and neck pathology.

[14]  T. Gupta,et al.  Prognostic factors in oropharyngeal cancer – analysis of 627 cases receiving definitive radiotherapy , 2009, Acta oncologica.

[15]  A. Forastiere,et al.  Head and neck cancer: changing epidemiology, diagnosis, and treatment. , 2008, Mayo Clinic proceedings.

[16]  M. Poulsen,et al.  In Reference to Locally Advanced Tonsillar Squamous Cell Carcinoma: Treatment Approach Revisited , 2007, The Laryngoscope.

[17]  J. Weissfeld,et al.  11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours , 2006, British Journal of Cancer.

[18]  W. Mendenhall,et al.  Definitive Radiotherapy for Tonsillar Squamous Cell Carcinoma , 2006, American journal of clinical oncology.

[19]  K. Soo,et al.  Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison , 2005, British Journal of Cancer.

[20]  J. Jacobs,et al.  Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. , 2004, The New England journal of medicine.

[21]  S. Stringer,et al.  Radiation therapy for squamous cell carcinoma of the tonsillar region: a preferred alternative to surgery? , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  K. Chao,et al.  Carcinoma of the tonsillar fossa: prognostic factors and long-term therapy outcome. , 1998, International journal of radiation oncology, biology, physics.

[23]  É. Luporsi,et al.  Influence of tumoral, radiobiological, and general factors on local control and survival of a series of 361 tumors of the velotonsillar area treated by exclusive irradiation (external beam irradiation+brachytherapy or brachytherapy alone) , 1994, International journal of radiation oncology, biology, physics.

[24]  G. Browman,et al.  Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. , 1993, The New England journal of medicine.

[25]  Chad A. LaGrange,et al.  NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .

[26]  G. Calais,et al.  Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. , 1999, Journal of the National Cancer Institute.